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Abstract
Family caregiving towards the end-of-life entails considerable emotional, social, financial and
physical costs for caregivers. Evidence suggests that good support can improve caregiver
psychological outcomes. The primary aim of this study was to investigate the impact of using
the carer support needs assessment tool (CSNAT), as an intervention to identify and address
support needs in end of life home care, on family caregiver outcomes. A stepped wedge de-
sign was used to trial the CSNAT intervention in three bases of Silver Chain Hospice Care in
Western Australia, 2012-14. The intervention consisted of at least two visits from nurses (2-3
weeks apart) to identify, review and address caregivers’ needs. The outcomemeasures for
the intervention and control groups were caregiver strain and distress asmeasured by the
Family Appraisal of Caregiving Questionnaire (FACQ-PC), caregiver mental and physical
health as measured by SF-12v2, and caregiver workload asmeasured by extent of caregiver
assistance with activities of daily living, at baseline and follow up. Total recruitment was 620.
There was 45% attrition for each group between baseline and follow-upmainly due to patient
deaths resulting in 322 caregivers completing the study (233 in the intervention group and 89
in the control group). At follow-up, the intervention group showed significant reduction in care-
giver strain relative to controls, p=0.018, d=0.348 (95%CI 0.25 to 0.41). Priority support needs
identified by caregivers included knowing what to expect in the future, having time for yourself
in the day and dealing with your feelings and worries. Despite the challenges at the clinician,
organisational and trial levels, the CSNAT intervention led to an improvement in caregiver
strain. Effective implementation of an evidence-informed and caregiver-led tool represents a
necessary step towards helping palliative care providers better assess and address caregiver
needs, ensuring adequate family caregiver support and reduction in caregiver strain.
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Introduction
Family caregivers providing informal care in the home are major sources of support for people
with long-term illnesses and severe disabilities. Despite the significant contribution of family
caregivers to the economy in many developed countries, there is considerable evidence in the
national and international literature, of the physical, psychological and social morbidity associ-
ated with caregiving, highlighted in studies with adverse titles, such as: “Caring enough to be
poor” [1]; “Ignored and invisible” [2]; “Caregiving as a risk factor for mortality” [3]; “Missed
Opportunities” [4]; “Warning—caring is a health hazard” [5]; “Family caregivers and leisure:
an oxymoron?” [6]; “The hardest thing we have ever done: The social impact of caring for a
dying person in Australia” [7]. Caregivers tend to be overlooked and often referred to as “hid-
den patients” [8].
Studies have shown that caregivers with better experiences of end-of-life care were substan-
tially less depressed over time and had better bereavement outcomes [9,10]. While a wide re-
search literature base exists on caregiver interventions [11–13], more needs to be achieved
regarding demonstrating and validating robust and effective caregiver support interventions
and establishing ways of disseminating and sharing evidence of successful interventions that
address caregiver experiences and needs [14], and ameliorate the effects of caregiving [15,16].
As family caregivers experience numerous support needs, the challenge is to find accessible
and acceptable approaches for caregivers in order to meet their needs or interventions that ad-
dress the range of needs [17]. While ‘one to one’ interventions for caregivers have been re-
ported to be useful though expensive, group interventions can be hard for many caregivers to
undertake because of the need to be away from the care recipient [18,19].
Family caregivers need to be supported in their central role of caring and their support
needs well identified by the service providers. However, brief practical tools to assess their sup-
port needs have been lacking or consisted of indirect measures of caregiving difficulties, feel-
ings of burden, meaning and relationship issues [20]. The Carer Support Needs Assessment
Tool (CSNAT) is a validated evidence based tool developed for home based care to fill the gap
between validated research tools that have minor relevance to actual practice and more ad hoc
service-based assessment forms that lack an adequate evidence base [21,22].
The CSNAT adopts a screening format, structured around 14 broad support domains. This
format allows it to be brief but also comprehensive, enabling caregivers to identify the domains
in which they require further support which can then be discussed with health professionals.
Each item represents a core family caregiver support domain in end of life home care and these
domains fall into two distinct groupings: those that enable the caregiver to care and those that
enable more direct support for themselves.
Aims
Aims of the study were to investigate the impact of using the carer support needs assessment
tool (CSNAT), as an intervention to identify and address support needs in end of life home
care, on family caregiver outcomes such as strain, distress and mental and physical health; and
to describe the implementation strategies, identified support needs and provided solutions to
address the needs of family caregivers.
Method
The study was approved by the Curtin University Human Research Ethics Committee (HR 24/
2011) and the Silver Chain Human Research Ethics Committee (EC App 068). All participants
provided written informed consent to participate in this study and the two ethics committees ap-
proved this consent procedure. All aspects of the trial conformed to CONSORT requirements.
The Carer Support Needs Assessment Tool Trial
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Setting
The trial was conducted in Perth, Western Australia, in three sites of the Silver Chain Hospice
Care Service (SCHCS) in 2012–14. Silver Chain is Australia’s largest provider of home based
palliative care. The service is provided by an interdisciplinary team comprising general practi-
tioners with a special interest in palliative care, medical consultants, registrars, resident medical
officers, palliative care specialist nurses, counsellors, chaplains, care assistants, social workers
and volunteers, who work with the patient to control symptoms and address psychosocial
needs. Typically, nurses visit patients weekly and increase visits according to client needs for
care and symptom management and care assistants provide personal care visits three times per
week to daily depending on patient needs. The average length of stay with the service is approx-
imately 90 days.
Trial design
The study was a stepped-wedge cluster non-randomised trial. Each of the three bases under-
took the intervention in a stepped sequence wherein the CSNAT was introduced at each site at
different time points, with the pre-intervention period serving as a control period (Fig 1). Inter-
vention start times for each base were assigned by the researcher. The sequence was not rando-
mised because the service preferred to start with the site that undertook the pilot study
(described below), being more ready to implement the intervention. This also gave more time
for the other two sites to settle into this research study, in terms of adapting to all aspects of the
research process, before they were ready to implement the intervention.
A stepped-wedge design was considered more appropriate, cost effective and practical than
a cluster randomised controlled trial. As all sites start as controls, any baseline differences be-
tween sites can be ascertained. Also, a randomized controlled trial within each base was consid-
ered not feasible because contamination could occur as staff can be visiting clients in both
groups within each base [23,24].
Participants
Participants were primary family caregivers of terminally ill patients (with cancer or non-cancer
diagnoses) referred to Silver Chain Hospice Care. A primary family caregiver was defined as a
Fig 1. SteppedWedge Trial Design.
doi:10.1371/journal.pone.0123012.g001
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person who, without payment, provided physical care (and emotional care) to a person who was
expected to die during provision of the caring role. This care could be provided on a daily or in-
termittent basis. All adult caregivers (aged 18 years or older) who were able to read and write in
English were eligible for the study, unless the service had concerns about their ability to cope
with research because of the exceptionally high levels of distress. Family caregivers with a
known cognitive impairment were excluded based on the nurses’ clinical judgment.
Intervention and Training
The CSNAT intervention consisted of at least two visits from nurses to caregivers, 2 to 3 weeks
apart, where nurses incorporated the CSNAT into a practitioner facilitated but caregiver-led
approach to needs assessment and support. Family caregivers identified domains where they
needed more support. This was accomplished by the CSNAT being either self-completed by
the family caregiver or completed jointly with the nurse. Then a conversation took place to de-
termine individual needs and the caregiver’s priorities were discussed with the nurse to agree
on actions/solutions and a shared action plan.
Therefore nurses were trained in the use of the CSNAT as a caregiver-led approach for identi-
fying and addressing caregiver needs rather than the traditional way of professional-led approach.
One training session of 2–3 hours long was provided (mostly in groups of 6–8) at the start of data
collection for the intervention. Therefore, a total of six main training sessions (2 sessions for each
site) were undertaken to accommodate the availability of staff. Due to the additional time pressure
training sessions were perceived to add to the nurses’ busy schedules, we were asked to keep ses-
sions short and not so frequent. These initial training sessions were followed towards the middle
of the data collection period by three refresher sessions (1 session for each site) lasting 1–2 hours
to discuss nurses’ experiences, issues with recruiting and completing the intervention. In addition,
the research team had monthly meetings with the designated champion of the project in the ser-
vice (a senior clinical nurse manager) to follow progress and discuss challenges in each site. Sug-
gestions from the research team were relayed back by the champion to the recruiting nurses
during their regular weekly clinical meetings. Furthermore, nurses had daily access by phone to
the advice of the research nurse, and texting was the preferred way for individual nurses to liaise
with the research nurse.
All three sites commenced as control sites for the first time period (Fig 1). As each site en-
tered the intervention phase, the training for each intervention site was timed to be provided
immediately prior to the intervention commencing at the particular site. In general, each site
had its own staff, but sometimes a few were called upon to assist in another site for a short peri-
od if there were staff shortages due to sickness or other operational matters. However, to avoid
contamination across sites, efforts were made to ensure the nurses with intervention training
were not available to work with control group participants at another site.
The control group received ‘standard practice’ which consisted of the staff meeting with the
caregiver during the client visit and discussing caregiver needs on an informal basis. Following
this discussion, the staff member would offer services and equipment that Silver Chain was
able to provide. However many conversations were on an ad hoc basis and not documented.
Recruitment and data collection
At the start of the study, family caregivers of clients newly admitted or already receiving pallia-
tive care were invited by participating nurses to take part at the first feasible opportunity during
a face to face visit. Nurses obtained written informed consent for the study and for the re-
searcher to contact them by phone to undertake the pre and post intervention outcome mea-
sures. For the intervention group, once the researcher completed the pre-intervention outcome
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measures by phone with the caregiver, she informed the nurse who completed at least two visits
implementing the CSNAT intervention. Once the nurse completed the CSNAT visits, the re-
searcher was informed so post intervention outcome measures could be collected from the
caregiver by phone, aiming to do it within three to seven days. However this depended on how
soon the nurse informed the researcher and also on caregivers’ availability. To ensure that this
research process worked well, liaison between the researcher and the nurses occurred almost
on a daily basis. Deaths were monitored throughout the data collection period to ensure that
bereaved carers were not contacted by phone for completing the follow-up measures, as it was
not sensitive to do so once patient death occurred.
Nurses were also asked to keep a record on a specially designed form of those caregivers
who did not participate in the study (control or intervention, gender, age and reason for non-
participation).
Outcomes
Data collection by the researcher was undertaken at the individual participant level and con-
ducted at pre and post intervention over the phone for the two groups. Outcome measures
(Caregiver Survey) were collected by the researcher at both time points. Demographic data
were collected at baseline only and consisted of:
• Caregivers: age, gender, marital status, education, employment status, living arrangements,
ethnicity, relationship to patient; other caregiving responsibilities.
• Patients: age, gender, type of diagnosis, length of diagnosis, period receiving palliative care.
Primary outcome. The primary outcome was caregiver strain and distress as measured by
the 2 subscales of the Family Appraisal of Caregiving Questionnaire (FACQ-PC) where strain
has 8 items and distress has 4 items [25]. The appraisal of the strain subscale (also referred to
as index of burden) includes “items that have been closely linked to outcome, namely, role
overload (the extent to which caregivers perceive that they are physically or emotionally deplet-
ed by their caregiving activities), and role captivity (the extent to which caregivers feel trapped
by their responsibilities and isolated)” ([25], p. 615). The distress subscale represents “negative
emotional responses associated with caregiving such as anxiety and depression as well as feel-
ings of guilt in the caregiver-care recipient relationship” ([25], p. 616). Psychometric analyses
demonstrate good construct validity. Internal reliability estimates range from 0.75–0.86. Scores
range from 5 = strongly agree to 1 = strongly disagree.
Secondary outcomes. Secondary outcomes were caregiver mental and physical wellbeing
as measured by SF-12v2 and caregiver workload as measured by caregiver assistance with Ac-
tivities of Daily Living.
The SF-12v2 consists of 12 questions; relating to: physical health problems, bodily pain, gen-
eral health perceptions, vitality (energy/fatigue), social functioning, role limitations and general
mental health (psychological distress and psychological well-being). Reliability estimates range
from 0.93 to 0.95 [26].
Caregiver workload was measured by the nature and extent of assistance provided by the
family caregiver with a range of Activities of Daily Living (ADLs, such as feeding and toileting)
and Instrumental Activities of Daily Living (IADLs such as transport and shopping). Scores
are: 4 = assistance all of the time; 3 = assistance most of the time; 2 = occasional assistance;
1 = no assistance required.
The Carer Support Needs Assessment Tool Trial
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Pilot study
The study was first pilot tested to assess the feasibility and acceptability of the tools and the
data collection process by both nurses and caregivers, in one of the three service bases. Five
nurses and 21 family caregivers participated in the pilot study for a period of four months in
2011 and gave feedback that was incorporated in the present study. In general, completing the
CSNAT was very acceptable to the nurses and caregivers. The Caregiver Survey, which incor-
porated the outcome measures, was also acceptable to the caregivers in terms of content and
length. Recommended changes that were implemented in the present study included:
• CSNAT visits need to be undertaken by nurses every 2 weeks rather than 4 weeks to mini-
mise attrition due to patient deaths
• Nurses reported that it was time consuming for them during their visit to explain and assist
caregivers to complete the Caregiver Survey. Therefore, the data collection method needed to
change from caregivers self-administering the Caregiver Survey and then posting it to the re-
search team. Instead the research officer would assist caregivers to complete the survey via a
telephone call at a time that was convenient to them pre and post intervention, thus reducing
the burden of completing it during the nurse’s visit.
• The service decided to have more nurses involved in the larger trial to take the pressure off
recruiting, especially when the service encounters the same challenges experienced in the
pilot study such as higher patient workload or staff shortages in a particular time period.
Sample size
Previous research has found that caregivers who felt psychologically unsupported during care-
giving report worse mental health post bereavement (effect size 0.67) [27]. Assuming a more
modest effect size of 0.41 for the primary outcome measure (FACQ-PC), a sample size of 95 in
each group (intervention and control) would give 80% power to demonstrate an effect of the
intervention at alpha<0.05, two-tailed test between two independent groups using a standard
RCT [28]. A design effect correction of 1.62 was then applied to the estimated sample size to
adjust for the cluster design of the trial based on a conservative intraclass correlation coefficient
(ICC) of 0.01 and average cluster size of 63, The resulting required sample was 308 (154 care-
givers per group). We also applied a correction for an estimated 30% attrition rate, resulting in
a final a priori sample size of 440, or 220 in each group. This sample size was considered feasi-
ble based on the fact that on average 200 new patient referrals are received per month.
Statistical analysis
All statistical analyses were conducted using SPSS 22. Statistical significance was determined at
an alpha value of 0.05. Analyses of this trial were on a per protocol basis.
Continuous variables were reported as mean ± standard deviation and categorical variables
are reported as n (%). Baseline differences between Intervention and Control groups were as-
sessed using Mann-Whitney U Tests for continuous variables and Chi-square tests or Fisher’s
Exact Test (where cell sizes were less 5) for categorical variables. Cohen’s d and 95% Confi-
dence Intervals (CI) for calculating effect sizes was determined for the outcome measures.
Generalized linear mixed modelling (GLMM) was used to examine the efficacy of the
CSNAT intervention from baseline to post-treatment. GLMM is a regression-based approach
that provides a more powerful means of analysing clustered data when compared with more
conventional procedures for the comparison of group means by explicitly accounting for intra-
The Carer Support Needs Assessment Tool Trial
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cluster correlation [29]. Moreover, GLMM is robust to unequal group sizes, which was a signif-
icant issue in the present study [30].
A series of six GLMMs were run, one for each outcome. Each model included two random
effects; Base (to account for the intra-class correlation within bases) and Time (to account for
the correlation between repeated observations of the same individual). Fixed effects included
were; Time, Base, Condition, the interaction between Time and Condition (Time x Condition),
and the interaction between Time and Base (Time x Base). The Time × Condition interaction
effect was the primary variable of interest in each model with a significant interaction effect in-
dicating a differential rate of change in outcomes between the intervention and control condi-
tions from baseline to post-treatment. Five covariates were also included in each GLMM to
adjust for significant baseline differences between groups; Age of caregiver, effect of caring on
work, diagnosis of patient, length of palliative care, and length of Silver Chain admission.
Results
Participant flow
Fig 2 displays the participant flow for the study. In total, 620 caregivers (Intervention n = 441,
Control n = 179) were recruited and/or referred over a time period of 24 months (March 2012
to February 2014). The observed group imbalance was due to slow recruitment at the start of
the study as a result of logistical and operational service constraints, when all sites were recruit-
ing for the control group.
Thirty four individuals withdrew prior to baseline measures. Reasons for discontinuation
included; patient death (n = 22), did not meet eligibility criteria (n = 9), lost to follow-up
(n = 2) or caregiver withdrawal (n = 1). The remaining 586 caregivers (Intervention n = 423,
Fig 2. Flowchart of participants in the trial.
doi:10.1371/journal.pone.0123012.g002
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Control n = 163) completed baseline measures. Two hundred and thirty three participants
(55.1%) completed the study in the intervention group and 89 (54.6%) in the control group
after baseline measures. The attrition rate between baseline and follow-up was similar for both
groups (44.9% for the intervention group and 45.4% for the control group). This rate was sig-
nificantly higher than our estimated rate of 30%. Attrition was predominantly due to patient
deaths in both groups (Intervention: n = 151, 79.4% of all those withdrawn, Control: n = 68,
91.9% of all those withdrawn). Our analyses were based on the study completers sample only
(n = 322), or per protocol.
Compared to drop-outs, participants who completed the study had a longer period of car-
ing, were less likely to be in paid employment, and had more from a non-English background.
All other demographic variables were equivalent and patient profiles did not differ.
Participant characteristics
Table 1 displays demographic data at baseline for family caregivers who completed the study in
the two groups. Caregivers did not differ between the two groups on most characteristics except
that the intervention participants were slightly younger than the control participants, currently
engaged in paid employment, had care recipients with cancer diagnoses, with shorter median
lengths of stay (LOS) with Silver Chain and shorter median LOS in palliative care.
Information was collected on 121 non-participants and their basic demographics did not
differ from those of participants: 71% were women, mean age was 65 years and 75% were in
the intervention group. The predominant reasons for not participating were: too busy/over-
whelmed (43%), not interested (13%) and patient deteriorating or at terminal stage (8%).
Primary outcome: FACQ-PC
The intervention was associated with a significant reduction in Caregiver Strain, while control
participants experienced an increase in strain over the study period (Table 2). Mean reduction
in caregiver strain was 0.08 for intervention participants compared with an increase of 0.09 for
the control group after adjusting for covariates, p = 0.018, d = 0.348 (95% CI 0.25 to 0.41). Sim-
ilarly, intervention participants experienced a mean reduction of 0.10 in Caregiver Distress
scores from baseline to follow-up, while control participants experienced a mean increase of
0.04, although this result was not statistically significant after adjusting for covariates, p = 0.26,
d = 0.23 (95%CI 0.11 to 0.30).
Secondary outcomes
The intervention was also associated with an improvement in the SF12v2 Mental Component
Score (MCS). Mean improvement in MCS was 1.42 for the intervention group compared with
a decrease of 0.05 for the control group, although this result was not statistically significant
after adjusting for covariates, p = 0.67, d = 0.16 (95%CI -1.70 to 1.40). Both groups showed a
worsening on the SF12v2 Physical Component Score (PCS) over the two time points, but these
differences were not significant (Table 2).
Both groups showed increased caregiver workload assisting with patient activities of daily
living (ADLs) from baseline. However, this increase was smaller in the intervention group for
both the ADL and IADL measures, though the difference between groups was not statistically
significant after controlling for covariates.
The Carer Support Needs Assessment Tool Trial
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Table 1. Characteristics of groups who completed the CSNAT study.
Study Group
Intervention N = 233 Control N = 89 p-value
Silver Chain Base Base 1 108 (46.6%) 15 (16.9%)
Base 2 65 (27.9%) 35 (39.3%)
Base 3 60 (25.8%) 39 (43.8%)
FAMILY CARER
Gender 0.094
Male 69 (29.6%) 18 (20.2%)
Female 164 (70.4%) 71 (79.8%)
Age (yrs.) 0.016
Mean ± SD 62.1 ± 12.4 65.5 ± 13.16
Median (Range min., max.) 62.0 (20, 88) 67.0 (33, 92)
Marital status 0.217
Never married 13 (5.6%) 2 (2.2%)
Widowed 7 (3.0%) 2 (2.2%)
Divorced/separated 11 (4.7%) 9 (10.1%)
Married/de facto 202 (86.7%) 76 (85.4%)
Cultural background 0.111
Australian 129 (55.4%) 60 (67.4%)
Other English speaking 66 (28.3%) 21 (23.6%)
Non-English speaking 38 (16.3%) 8 (9.0%)
Usual employment 0.144
Paid employment 74 (31.8%) 17 (19.1%)
Pensioner 96 (41.2%) 44 (49.4%)
Self-funded retiree 35 (15.0%) 15 (16.9%)
Other 28 (12.0%) 13 (14.6%)
Education 0.502
No formal education 1 (0.4%) 0
Primary 5 (2.1%) 1 (1.1%)
Secondary 133 (57.1%) 57 (64.0%)
Tertiary 94 (40.3%) 31 (34.8%)
Living arrangements 0.158
Private residence 223 (95.7%) 81 (91.0%)
Retirement village 7 (3.0%) 7 (7.9%)
Other 3 (1.3%) 1 (1.1%)
Relationship 0.644
Spouse 157 (67.4%) 63 (70.8%)
Parent 4 (1.7%) 3 (3.4%)
Adult Child 52 (22.3%) 16 (18.0%)
Sibling 5 (2.1%) 3 (3.4%)
Other 15 (6.4%) 4 (4.5%)
Caring affected work 0.007
Gave up job 41 (17.7%) 16 (18.0%)
Reduced hours 27 (11.6%) 8 (9.0%)
No change 22 (9.5%) 2 (2.2%)
Not working 115 (49.6%) 60 (67.4%)
Other 27 (11.6%) 3 (3.4%)
(Continued)
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Table 1. (Continued)
Study Group
Intervention N = 233 Control N = 89 p-value
Other caring responsibilities 0.375
Yes 57 (24.5%) 17 (19.1%)
No 176 (75.5%) 72 (80.9%)
Caring length (months) Mean (± SD) 21.7 ± 43.48 18.4 ± 24.39
Median (Range) 10.0 (0.3, 420) 11.0 (1, 144) 0.498
PATIENT
Patient gender 0.452
Male 130 (55.8%) 54 (60.7%)
Female 103 (44.2%) 35 (39.3%)
Patient age (years) 0.172
Mean (± SD) 70.3 ± 13.37 72.1 ± 14.29
Median (Range) 72.0 (28, 94) 74.0 (4, 93)
Diagnosis 0.029
Cancer 175 (75.1%) 66 (74.2%)
Cancer + non-cancer 39 (16.7%) 8 (9.0%)
Non-cancer 19 (8.2%) 15 (16.9%)
Length of diagnosis (months) Mean (± SD) 30.3 ± 49.84 31.1 ± 50.89
Median (Range) 13.0 (0.3, 420) 13.0 (1, 400) 0.697
Length of palliative care (months) Mean (± SD) 2.9 ± 4.24 6.0 ± 8.29
Median (Range) 1.5 (0.3, 29) 4.0 (0.3, 72) 0.000
Length of stay with Silver Chain (months) Mean (± SD) 2.3 ± 3.75 5.1 ± 5.19
Median (Range) 0.9(0.03, 4.16) 3.2(0.03, 7.95) 0.000
Table 2. Mean change in domain scores for FACQ-PC, SF-12v2, and ADL/IADL from baseline to follow-up.
Time Intervention (n = 233) Control (n = 89) Adjusted p-value1 Effect size2 (95%CI)
Mean (SD) Mean (SD)
FACQ-PC3 Caregiver Strain 1 2.92 (0.87) 2.92 (0.87) 0.018* 0.348 (0.25–0.41)
2 2.84 (0.72) 3.01 (0.82)
Caregiver Distress 1 3.13 (0.76) 3.20 (0.88) 0.261 0.231 (0.11–0.30)
2 3.03 (0.70) 3.24 (0.84)
SF-12v24 MCS 1 43.13 (10.59) 44.90 (12.56) 0.678 0.156 (-1.70–1.40)
2 44.48 (10.51) 44.85 (11.53)
PCS 1 51.93 (9.65) 50.53 (11.78) 0.975 0.000 (-1.36–0.87)
2 51.29 (9.97) 48.94 (11.12)
Assistance with ADL’s3 ADL 1 1.72 (0.76) 1.71 (0.80) 0.090 0.255 (0.13–0.34)
2 1.85 (0.82) 2.00 (0.88)
IADL 1 3.46 (0.49) 3.43 (0.57) 0.502 0.133 (0.04–0.17)
2 3.47 (0.50) 3.48 (0.56)
1 p-value for the Time x Condition interaction effect adjusted for cluster effect, age of carer, effect of caring on work, diagnosis of patient, length of
palliative care, length of Silver Chain admission
2 Cohen’s d
3 Higher scores indicate greater strain, stress and tasks assisting the patient
4 Higher scores indicate greater wellness.
* p < 0.01
doi:10.1371/journal.pone.0123012.t002
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Implementation of the CSNAT
Two hundred and thirty three family caregivers experienced the CSNAT intervention. The
mean period between the two visits by nurses, where CSNAT was undertaken, was 23 days
(SD = 14), and the mean period between baseline and follow-up data collection for outcome
measures was 43 days (SD = 20).
Family caregivers’ support needs. The top four support needs reported by family caregiv-
ers at the first and second nurse visits consisted of (Fig 3): knowing what to expect in the future
(52%, 32% respectively), having time for yourself in the day (40%, 36% respectively), dealing
with your feelings and worries (33%, 28% respectively) and understanding your relative’s ill-
ness (28%, 20% respectively).
Solutions provided. The solutions put in place by the nurses for “knowing what to expect
in the future” consisted of discussions (using nurses’ quotes) “on what to expect as [client’s]
condition deteriorates and death nears”, “recommended the Helpful Comfort Measures book-
let” or “long talk about end of life care/dying at home/ symptom management with [infusion]
pump/ extra input from care aides”. For the second priority on “having time for yourself in the
day”, the nurses discussed "time out", the options of respite care, family rosters, volunteers and
personal alarm for the client.
The solutions put in place for the third priority “dealing with your feelings and worries”
consisted of: seeing a counsellor, a chaplain, encouragement to attend the day centre at Com-
munity Hospice and to call on friends for support, and referral to social worker regarding
Fig 3. Percentage of family carers expressing need for more support with each CSNAT domain during first and second visit from nurse.
doi:10.1371/journal.pone.0123012.g003
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financial aspects of funerals. For the fourth priority “understanding your relative’s illness”, the
nurses provided explanations on matters such as: signs of seizure activity and how to respond,
more invasive tests might be required so need to gain more information from the specialist and
providing information for the children from the cancer support service.
Discussion
This study is the first to test the CSNAT intervention through the caregiving period (in contrast
to an UK trial that focused on post bereavement outcome measures [31]), using a control
group, and all sites received the intervention using the stepped wedge design. The Intervention
was associated with a significant reduction in caregiver strain. A reduction in caregiver distress
was also indicated but not significant after controlling for covariates. Both groups showed an
increase in caregiver workload (assisting with ADLs) which was expected given the nature of
disease progression with time. However the intervention was associated with a smaller increase
in caregiver workload. The differences in SF12v2 scores were not significant maybe due to
SF12v2 not accurately capturing the outcome for the study within a short time period of the in-
tervention or the intervention had limited effect in this case.
The observed significant small to moderate effect size of this intervention (d = 0.348, 95%
CI 0.25 to 0.41) is comparable if not larger than those reported in a meta-analysis of caregiver
interventions by Northouse et al [32]. Specifically, reported interventions on appraisal of care-
giver burden had effect sizes (Hedges’ g) with confidence intervals ranging from 0.08 (95% CI
-0.19 to 0.34) to 0.22 (95% CI 0.08 to 0.35). Our obtained effect size of 0.348 means that 64% of
the control group would have a score below the average participant in the intervention group
[33]. Northouse et al concluded that even though effects were small to moderate in size, these
interventions have significantly reduced caregivers’ burden among other positive outcomes,
and therefore they show promise of achieving clinically significant outcomes, “as these inter-
ventions produce more prepared, less distressed caregivers which in turn is likely to result in
more positive benefits for patients” ([32], p. 12).
The profile of the study sample is similar to that in many studies where family caregivers are
predominantly women, spouses, retirees, and caring for older family members with mainly a
malignant disease, and in particular comparable to a study from the UK [21]. It is also worth
noting that the four priorities in support needs for family caregivers in this Australian study
were similar to those obtained in the UK study [21].
Most of the solutions put in place had the opportunity to be enacted upon in the period be-
tween baseline and follow-up (mean period was 43 days), as with close to half of the patients
dying, it was not feasible to extend further the timing of obtaining the follow-up outcome mea-
sures. By structuring and reviewing caregivers’ needs 2–3 weeks apart, Fig 3 gives some demon-
stration of a steady reduction in the caregivers’ perception of needs between the two CSNAT
visits, thus providing good evidence that some of the needs have been addressed through the
solutions provided. This reinforces the benefit of systematically repeating this review of needs
using the CSNAT approach. The single domain that revealed a rise in need over time was get-
ting a break overnight, which became important across time. This could reflect the benefit of
recognition by caregivers that their own needs have become more visible and acknowledged
now, thus feeling that their request to have a break is more legitimised [21,34].
We believe the intervention has targeted those it was meant for, family caregivers of patients
in hospice care and therefore close to death. Our reported 45% attrition rate was because the
carers could not complete the post-intervention outcome measures due to patient deaths and
not because they did not have time or did not want to do the intervention. In fact the qualita-
tive feedback obtained from the 233 family carers in the intervention group was
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overwhelmingly positive [34]. Just a few stated that they would have preferred going through
the CSNAT earlier to prepare them more for what is to come and some thought it was too
early for them to know about the challenges they are going to face. The timing of the interven-
tion when used in routine practice (without the constraints of the research process) is a call the
nurses will need to make and gauge the best time to introduce the CSNAT.
Limitations and direction for future research
Primary limitations of the study include the high attrition rate, unbalanced groups, and the
non-randomised design being typical challenges reported in undertaking research in palliative
care [35]. As explained below, these challenges operated at three levels: the individual clinician
level, the structural or organisational level, and the research trial level.
We had aimed to recruit 440 participants (220 per condition) at baseline, which a priori
sample size calculations indicated would be sufficient to adequately power the trial, with an an-
ticipated 30% attrition rate. However, the observed attrition rate (45%) in the trial was greater
than we initially estimated, due to a high rate of patient deaths over the study period. The trial
was thus ultimately underpowered with a final sample size of 322 completers. Attrition rates as
high as 69%, causing studies to be underpowered to detect intervention effects, were reported
in a meta-analysis of several studies [32].
Use of a study completers sample may also impact on interpretation of findings. Given that
the leading cause of attrition was patient deaths, drop outs are likely to have experienced in-
creased strain and distress and caregiver burden over the study period. Limiting our analyses to
only study completers may thus have overstated the effect of the intervention. However, we felt
it was inappropriate to use estimation methods to replace missing data for drop-outs given the
high rate of attrition and non-random nature of missing values.
Moreover, most if not all of the drop outs (other than those due to patient deaths, Fig 2)
were not related to the intervention to warrant adopting a proposed approach that sits between
intention-to-treat and per protocol analyses, which is the palliative-modified ITT analysis [36].
This new approach recommends including in the analysis those drop outs related to the inter-
vention. However, the most common reasons for drop outs in our study were the progression
of the disease or the patient reaching terminal stage. Another reason for dropping out, dis-
charge from the service, was the result of the service operational changes whereby clients
deemed not close to death were discharged and then readmitted at a later date if their condition
deteriorated. These changes were made due to increased demand on the service and limited re-
sources and took effect after the first time period of recruitment for the control arm, and there-
fore would have affected more the intervention arm.
Another limitation of our study was unbalanced groups, with almost three times as many
participants in the intervention (n = 233) than control group (n = 89). This was due to slow re-
cruitment at the start of the trial, when all sites were recruiting for the control group. The ser-
vice nearly doubled (to 44) the number of nurses recruiting for the intervention to allow for
quicker recruitment in the timeframe of the extended data collection period.
Not all caregivers would have been approached to participate and therefore there could be a
risk of systematic selection bias. While we cannot rule out that gatekeeping took place, we be-
lieve that in many cases the decision to include a caregiver in the study would have been most
likely influenced by the workload of the nurse on the day and how time-pressured she/he felt fit-
ting in a number of patients that need to be visited. Nurses voiced their concerns at our meetings
about how time consuming and burdensome the research process was, issues well reported in
the literature [37,38]: Consenting caregivers and then contacting the researcher to conduct the
baseline measurements before being able to undertake the CSNAT which would be in a second
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visit. Moreover the majority of these nurses worked part-time or job-shared and handover issues
were not straightforward. However the profiles of non-participants and participants did
not differ.
The issue of unbalanced groups ultimately is an inherent limitation of the stepped-wedge
design; however, GLMM is generally robust to unbalanced groups. Relatedly, the intervention
and control groups were found significantly different on a number of baseline characteristics.
While analyses were adjusted for these differences, other potential underlying biases cannot be
completely ruled out.
Finally, randomisation of intervention start times was not implemented in the present study
due to logistic constraints. The service base that participated in the pilot study was assigned to
start intervention first in the main trial in order to allow the remaining two bases a longer time
to settle into this research study before they were ready to implement the CSNAT. Therefore,
readiness to participate and experience in CSNAT may present as confounders, although it is
encouraging to note that the Time x Base interaction effect was not significant in the GLMMs
for all six outcomes, indicating that change in outcomes did not differ significantly
between bases.
Conclusion
Despite the described unavoidable challenges which operated at three levels, the individual cli-
nician level, the structural or organisational level, and the research trial level, this study has
provided sound evidence to support everyday clinical practice. The CSNAT implementation
led to an improvement in caregiver strain during the caregiving period within this research
context. While more research is needed on the effectiveness of the CSNAT in similar and other
settings, the comprehensive quantitative and qualitative feedback obtained from all 233 care-
givers [34] in the intervention group and the 44 nurses who implemented the intervention
(under review), has been positive and encouraging that its implementation into routine prac-
tice can be explored in this service context.
As very few of such evidence-based interventions have been translated for or implemented
in clinical practice settings, Northouse et al called for more collaborative effort between re-
searchers and clinicians to move efficacy studies (phase III) to effectiveness studies (phase IV)
[32]. Only then, we may see a reduction in publications reporting negatively on family caregiv-
ing experience, nationally and internationally.
Effective implementation of an evidence-informed tool represents a necessary step towards
helping palliative care providers better assess and address caregiver needs, ensuring adequate
family caregiver support and reduction in caregiver strain throughout the caregiving journey.
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